A review of Trimethylaminuria: (Fish odor syndrome)

Journal of Clinical and Aesthetic Dermatology

Volumn 6, Issue 11, 2013, Pages 45-48

  Messenger, Jeffrey ^a   Clark, Shane ^b   Massick, Susan ^b   Bechtel, Mark ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; AMOXICILLIN; FLAVIN MONOOXYGENASE 3; METRONIDAZOLE; NEOMYCIN; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

ANXIETY; DEPRESSION; DIAGNOSTIC TEST; DIET RESTRICTION; DISTRESS SYNDROME; EXERCISE; GENETIC SCREENING; HUMAN; METABOLIC DISORDER; MOOD DISORDER; REVIEW; SELF ESTEEM; SHAME; SOCIAL PSYCHOLOGY; SUICIDE ATTEMPT; TRIMETHYLAMINURIA;

EID: 84888592962     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Treacy EP, Akerman BR, Chow LM, et al. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxification. Hum Mol Genet. 1998;7:839-845.
2. Ziegler DM. Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metab Rev. 1988;19:1-32.
3. Jones KC, Ballou DP. Reactions of the 4a-hydroperoxide of liver microsomal flavin-containing monooxygenase with nucleophilic and electrophilic substrates. J Biol Chem. 1986;261:2553-2559.
4. Humbert JA, Hammond KB, Hathaway WE, et al. Trimethylaminuria: the fish-odour syndrome. Lancet. 1970;2:770-771.
5. Mitchell SC, Smith RL. Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos. 2001;29:517-521.
6. Wise PM, Eades J, Tjoa S, et al. Individuals reporting idiopathic malodor production: demographics and incidence of trimethylaminuria. Am J Med. 2011;124:1058-1063.
7. Al-Waiz M, Ayesh R, Mitchell SC, et al. A genetic polymorphism of the N-oxidation of trimethylamine in humans. Clin Pharmacol Ther. 1987;42:588-594.
8. Mitchell SC, Zhang AQ, Barrett T, et al. Studies on the discontinuous N-oxidation of trimethylamine among Jordanian, Ecuadorian and New Guinean populations. Pharmacogenetics. 1997;7:45-50.
9. Mountain H, Brisbane JM, Hooper AJ, et al. Trimethylaminuria (fish malodour syndrome): a "benign" genetic condition with major psychosocial sequelae. Med J Aust. 2008;189:468.
10. Ayesh R, Mitchell SC, Zang A, Smith RL. The fish odour syndrome: biochemical, familial, and clinical aspects. BMJ. 1993;307:655-657.
11. Todd WA. Psychosocial problems as the major complication of an adolescent with trimethylaminuria. J Pediatr. 1979;94:936-937.
12. Asatoor AM, Simenhoff ML. The origin of urinary dimethylamine. Biochim Biophys Acta. 1965;111:384-392.
13. Zeisel SH, Wishnok JS, Blusztajn JK. Formation of methylamines from ingested choline and lecithin. J Pharmacol Exp Ther. 1983;225:320-324.
14. Zeisel SH, Da Costa KA, Youssef M, Hensey S. Conversion of dietary choline to trimethylamine and dimethylamine in rats: dose-dependent relationship. J Nutr. 1989;119:800-804.
15. Growdon JH, Cohen EL, Wurtman RJ. Huntington's disease: clinical and chemical effects of choline administration. Ann Neurol. 1977;1:418-422.
16. Etienne P, Gauthier S, Johnson G, et al. Clinical effects of choline in Alzheimer's disease. Lancet. 1978;1:508-509.
17. Ruocco V, Florio M, Filioli FG, et al. An unusual case of trimethylaminuria. Br J Dermatol. 1989;120:459-461.
18. Marks R, Dudley F, Wan A. Trimethylamine metabolism in liver disease. Lancet. 1978;1:1106-1107.
19. Mitchell S, Ayesh R, Barrett T, Smith R. Trimethylamine and foetor hepaticus. Scand J Gastroenterol. 1999;34:524-528.
20. Rehman HU. Fish odor syndrome. Postgrad Med J. 1999;75:451-452.
21. Blumenthal I, Lealman GT, Franklyn PP. Fracture of the femur, fish odour, and copper deficiency in a preterm infant. Arch Dis Child. 1980;55:229-231.
22. Mayatepek E, Kohlmüller D. Transient trimethylaminuria in childhood. Acta Paediatr. 1998;87:1205-1207.
23. Cashman JR, Camp K, Fakharzadeh SS, et al. Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria. Curr Drug Metab. 2003;4:151-170.
24. Zhang AQ, Mitchell SC, Smith RL. Exacerbation of symptoms of fish-odour syndrome during menstruation. Lancet. 1996;348:1740-1741.
25. Mitchell SC, Smith RL. A physiological role for flavincontaining monooxygenase (FMO3) in humans? Xenobiotica. 2010;40:301-305.
26. Shimizu M, Cashman JR, Yamazaki H. Transient trimethylaminuria related to menstruation. BMC Med Genet. 2007;8:2.
27. Shephard EA, Treacy E P, Phillips IR. Clinical utility gene card for: trimethylaminuria. Eur J Hum Genet. 2012;20(3). Epub 2011 Nov. 30.
28. Walker V. The fish odour syndrome. BMJ. 1993;307:639-640.
29. Christodoulou J. Trimethylaminuria: an under-recognised and socially debilitating metabolic disorder. J Paediatr Child Health. Epub 31 January 2011.
30. Lin J, Cashman JR. Detoxication of tyramine by the flavincontaining monooxygenase: stereoselective formation of the trans oxime. Chem Res Toxicol. 1997;10:842-852.
31. Arseculeratne G, Wong AK, Goudie DR, Ferguson J. Trimethylaminuria (fish-odor syndrome): a case report. Arch Dermatol. 2007;143:81-84.
32. Mackay RJ, McEntyre CJ, Henderson C, et al. Trimethylaminuria: causes and diagnosis of a socially distressing condition. Clin Biochem Rev. 2011;31:33-43.
33. Wevers RA, Engelke UF. Trimethylaminuria. In: Blau N, ed. Laboratory Guide to the Methods in Biochemical Genetics. New York: Springer-Verlag; 2008;781-792.
34. Danks DM, Hammond J, Schlesinger P, et al. Trimethylaminuria: diet does not always control the fishy odor. N Engl J Med. 1976;295:962.
35. Wilcken J. Acid soaps in the fish odour syndrome. BMJ. 1993;307:1497.
36. Chalmers RA, Bain MD, Michelakakis H, et al. Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children. J Inherit Metab Dis. 2006;29:162-172.
37. Zeisel SH, Albright CD, Shin OH, et al. Choline deficiency selects for resistance to p53-independent apoptosis and causes tumorigenic transformation of rat hepatocytes. Carcinogenesis. 1997;18:731-738.
38. Zeisel SH. Choline, an essential nutrient for humans. Nutrition. 2000;16:669-671.
39. Buchman AL, Dublin MD, Moukarzel AA, et al. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology. 1995;22:1399-1403.
40. Grön G, Brandenburg I, Wunderlich AP, Riepe MW. Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis. Neurobiol Aging. 2006;27:78-87.
41. Holmes-McNary MQ, Loy R, Mar. M-H, et al. Apoptosis is induced by choline deficiency in fetal brain and in PC12 cells. Brain Res Dev Brain Res. 1997;101:9-16.
42. Sweiry JH, Yudilevich DL. Characterization of choline transport at maternal and fetal interfaces of the perfused guinea-pig placenta. J Physiol. 1985;366:251-266.
43. Sweiry JH, Page KR, Dacke CG, et al. Evidence of saturable uptake mechanisms at maternal and fetal sides of the perfused human placenta by rapid paired-tracer dilution: studies with calcium and choline. J Dev Physiol. 1986;8:435-445.
44. Zeisel SH, Mar. M-H, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr. 2003;133:1302-1307.
45. Busby MG, Fischer L, Da Costa K, et al. Choline- and betainedefine diets for use in clinical research and for the management of trimethylaminuria. J Am Diet Assoc. 2004;104:1836-1845.
46. Cashman JR, Xiong Y, Lin J, et al. In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles. Biochem Pharmacol. 1999;58:1047-1055.
47. Fenwick GR, Butler E J, Brewster MA. Are brassica vegetables aggravating factors in trimethylaminuria (fish odour syndrome) ? Lancet. 1983;2:916.
48. Yamazaki H, Fujieda M, Togashi M, et al. Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients. Life Sci. 2004;74:2739-2747.
49. Treacy E, Johnson D, Pitt JJ, Danks DM. Trimethylaminuria, fish odour syndrome: a new method of detection and response to treatment with metronidazole. J Inherit Metab Dis. 1995;18:306-312.
50. Fraser-Andrews EA, Manning NJ, Ashton GH, et al. Fish odour syndrome with features of both primary and secondary trimethylaminuria. Clin Exp Dermatol. 2003;28:203-205.
51. Pike MG, King GS, Pettit BR, et al. Lactulose in trimethylaminuria, the fish-odour syndrome. Helv Paedriatr Acta. 1989;43:345-348.